Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04962815 · ClinicalTrials.gov registry record

Ceribell Delirium Data Collection Study

A clinical trial of Delirium, sponsored by Ceribell.

Recruiting
Registry status
200
Enrollment target
7
Study locations

NCT04962815 is a study of Delirium that is actively recruiting participants, run by Ceribell. The registered enrollment target is 200 participants, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (77% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04962815, a study of Delirium, is actively recruiting participants, sponsored by Ceribell.

RECRUITING
Registry status
200 participants
Enrollment target
7
Study locations

Study Summary

This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.

Conditions Studied

Interventions

  • DEVICE Electroencephalogram (EEG) Test

Study Locations (7)

California

  • Stanford University - Stanford

Florida

  • Naples Community Hospital - Naples

Iowa

  • University of Iowa Hospitals & Clinics - Iowa City

Missouri

  • Mercy - St Louis

New Jersey

  • Cooper Health - Camden

North Carolina

  • UNC Health Rex - Raleigh

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-11-10
Est. Completion 2026-04-01

Sponsor

Ceribell

4 total trials

What the Registry Record Tells You About NCT04962815

The ClinicalTrials.gov registry entry for NCT04962815 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (77% lower). The listed sponsor is Ceribell, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which Electroencephalogram (EEG) Test is the first listed.

NCT04962815 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Iowa.

Frequently Asked Questions

What is clinical trial NCT04962815 about?

NCT04962815 is a clinical study titled "Ceribell Delirium Data Collection Study". This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the...

What is the current status of trial NCT04962815?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2021-11-10. Estimated completion is 2026-04-01.

What conditions does trial NCT04962815 study?

This clinical trial studies the following conditions: Delirium.

What interventions are being tested in trial NCT04962815?

The interventions under investigation include: Electroencephalogram (EEG) Test (DEVICE).

Who is sponsoring clinical trial NCT04962815?

This trial is sponsored by Ceribell, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04962815 being conducted?

This trial has 7 study locations across California, Florida, Iowa, Missouri, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.